INTRODUCTION
Measles (also known as rubeola or morbilli) is one of the world's oldest and most deadly preventable diseases in human beings. It is a highly contagious viral infection and a known infectious disease of the respiratory system caused by a virus of the paramyxovirus family (known as Morbillivirus). The isolation of the measles virus in 1954 and the introduction of the vaccine in 1963 represent milestones of scientific efforts concerning measles research.
Measles still plays a significant role in terms of morbidity-and mortality-rates especially in developing countries, particularly in parts of Africa and Asia. However, in the Northern Hemisphere, the incidence tends to rise in winter and in tropical regions epidemics are less marked. In industrialized countries, however, smaller epidemics are occasionally registered. In the pre-vaccination era, the maximum incidence was seen in children aged 5 to 9 years. With the introduction of the vaccine, measles infection has shifted to the teens in countries with an efficient programme. In contrast, in third world countries, measles infection has its greatest incidence in children less than 2 years of age. Severe measles is more likely among poorly nourished young children, especially those with insufficient vitamin A or whose immune systems have been weakened by HIV/AIDS or other diseases.
Worldwide, the number of reported measles cases declined by 67% from 852,937 in 2000 to 278,358 in 2008. Despite the availability of a safe and effective measles vaccine since 1963, an estimated 750, 000 measles deaths occurred worldwide as recently as 2000. In 2005, the WHO made a commitment to reduce measles morbidity by 90% by the end of the first decade of the millennium. The WHO member states reaffirmed the commitment at the 2008 assembly. The WHO-UNICEF strategy was to reduce the measles mortality target in 47 countries for more than 97% immunization coverage with the routinely scheduled first dose of vaccine to be followed by a second routine dose of vaccine (supplementary dose) to the 1-year-old children along with effective laboratory surveillance and provision of appropriate clinical management for measles cases. From 2000 to 2008, nearly 700 million children aged 9 months to 14 years living in high-risk countries were vaccinated against the disease. As a result, global measles deaths declined by 78%, from an estimated 733,000 deaths in 2000 to 164,000 in 2008, but the reduction in measles mortality has been leveling off since 2007. The overwhelming majority (more than 95%) of measles deaths occur in countries with low per capita incomes and weak health infrastructures (WHO, 2012) .
The Measles Initiative is a collaborative effort of WHO, UNICEF, the American Red Cross, the United States Center for Disease Control and Prevention and the United Nations Foundation which plays a key role in advancing the global measles strategy. The fourth Millennium Development Goal (MDG 4) aims to reduce the under-five mortality rate by two-thirds between 1990 and 2015. Recognizing the potential of measles vaccination to reduce child mortality and given that measles vaccination coverage can be considered a marker of access to childhealth services, routine measles vaccination coverage has been selected as an indicator of progress towards achieving MDG 4.
So far only one specific scientometric study of measles research output covering the period, 1900-2008 and using ISI-Web of Science database has been conducted as part of a doctoral thesis (not published and only abstract available), where 14,254 publications could be identified in terms of the years, countries, journals and institutions of publication (Rospino, 2009 ).
Among other papers, Kouadio, Kamigaki and Oshitani have reviewed the published articles on measles outbreaks that occurred between 1979 and 2005 in Asia and Africa using PubMed database and found that measles patterns have varied over time among populations displaced by natural and man-made disasters (Kouadio, 2010) .
Guillaume and Bath have examined the content of mass media articles about the measles, mumps and rubella (MMR) vaccine and found that the content and format of articles between different information sources varied widely (Guillaume, 2008) .
OBJECTIVES
The paper analyses the publication growth and citation quality of worldwide research in measles during the period 2001-2010. It analyses the format and type of literature, language and country-wise contribution and collaborative linkages among them, major productive journals, leading institutions and authors contributing to measles research and also analyses the characteristics of its highly-cited papers. In addition, it analyses the subjectwise contribution of measles research, besides identifying important keywords and the different types of complications of measles research. The association of measles with all other diseases was also identified using co-word analysis. It also identifies the focus of measles research on different types of population groups such as children, adults, etc.
METHODOLOGY AND SOURCES
For analyzing the worldwide measles literature, the Scopus database was used to retrieve publication data published during the period 2001-2010. The main search strategy was developed by using and searching the following key terms in 'Title-Abstract-keywords' field of the database: 'measle or rubeola or morbilli' by making the following string:
(TITLE-ABS-KEY(measle*) OR TITLE-ABS-KEY (rubeola OR morbilli)) AND PUBYEAR > 2000 AND PUBYEAR < 2011.
To retrieve the published data of different countries, the above main string was combined with a particular country string as follows: (Table 2 ). In contrast, most developing Table 2 (Table 2 ).
In terms of citation quality (as measured by the number of citations received on a three-year citation window), Switzerland tops the list with an average citation per paper of 12.68, followed by USA (9.27), Israel (9.19), Sweden (9.10), Netherlands (8.54) , Belgium (7.85), UK and Canada (7.73 each), Australia (7.59), etc. (Table 2 ). 
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MEASLES RESEARCH OUTPUT IN THE CONTEXT OF DIFFERENT SUBJECTS
On analyzing the publication data, it was found that the world's research output in measles during [2001] [2002] [2003] [2004] [2005] [2006] [2007] [2008] [2009] [2010] has been published in context of 10 broad subjects (as reflected in database classifications based on journal subjects) with the highest publications output coming from medicine (7148 papers and 72.72% share), followed by immunology & microbiology (2460 papers, 25.03% share), biochemistry, genetics and molecular biology (1043 papers, 10.61% share), pharmacology, toxicology and pharma ceutics (795 papers, 8.09% share), veterinary science (662 papers, 6.74% share), agricultural and biological sciences (282 papers, 2.87% share), etc ( (Table 6 ).
In terms of citation impact (as measured by citations received on a three-years citation window), immunology and microbiology made the highest citation impact of 7.79 citations per paper, followed by biochemistry, genetics and molecular biology (7.54), neurosciences (6.80), veterinary science (5.89), environmental science (5.64), medicine (5.10), agricultural and biological sciences (4.36), public health (4.35) and pharmacology, toxicology and pharmaceutics (3.40) ( Table 6 ).
DISTRIBUTION OF PAPERS BY DIFFERENT TYPES OF POPULATION GROUPS
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SUBJECT-WISE DISTRIBUTION USING KEYWORDS
In terms of important keywords, the largest emphasis was on measles vaccine (with 2520 papers), followed by measles virus (2505 papers 
DISTRIBUTION OF PAPERS BY MEASLES COMPLICATIONS
Among measles complications, the largest number of papers were on respiratory infection (777 papers), followed by encephalitis (735 papers), pneumonia (615 papers), diarrhoea (560 papers), ear infections (511 papers), pregnancy (506 papers), subactute sclerosing (330 papers), actute encephalitis (138 papers), otitis media (126 papers), etc. during 2001-2010. In terms of activity index, the emphasis increased in the case of respiratory infections, pneumonia, diarrhea, blindness, bronchitis, thrombocytopenia purpura, mycarditis, corneal scarring and corneal ulceration, as against a decrease in the case of encephalitis, ear infection, pregnancy and sub actuate sclerosing from 2001-2005 to 2006-2010 (Table 8) .
RELATEDNESS OF VARIOUS DISEASES TO MEASLES AS REFLECTED THROUGH CO-OCCURENCES
A number of other diseases play an important role in the spread of measles. In this section, the co-occurrences of keywords associated with measles with a number of other diseases were studied during 2001-2010. It was found that measles keywords have comparatively a higher frequency of co-occurrences with rubella (4353), followed by mumps (4129 papers), tetanus (2122 papers), diphtheria (2039 papers), pertusis (2031 papers), poliomyelitis (1878 papers), hepatitis B (1859 papers), hepatitis A (1717 papers), influenza (1593 papers), chickenpox (1267 papers), pneumococcus (825 papers), tuberculosis (Table 9) .
RESEARCH PROFILE OF MOST PRODUCTIVE INSTITUTIONS IN MEASLES RESEARCH
The top 15 most productive institutions involved in measles research have published 58 and more papers each (Table 10) .
CONTRIBUTIONS AND IMPACT OF MOST PRODUCTIVE AUTHORS IN MEASLES RESEARCH
Fifteen authors have been identified, who have published 35 and above papers in measles. These 15 authors together contributed 744 papers with an average of 49.6 papers per author and account for 7.57% share in the cumulative publications output of measles during 2001-2010. Seven authors have published a higher number of papers than the group average (49.6). Considering the quality/impact of papers, these productive authors have received a total of 9359 citations for 744 papers with an average of 12.58 citations per paper. Six authors have registered a higher impact than the average impact of papers of all authors (12.58). (Table 12 ).
HIGHLY CITED PAPERS
The papers that received above 100 citations (since their publication till May 2011) are considered as highly cited These 77 high-cited papers involved institutions from 19 countries, with the highest number of papers (41 from 38 institutions) from USA, followed by UK (15 papers from 17 institutions), Switzerland (8 papers from 5 institutions), Germany (6 papers from 6 institutions), Canada (6 papers from 6 institutions), Australia (3 papers), 
